5.05

0.20% -0.010

enVVeno Medical Corporation (NVNO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

enVVeno Medical Corporation stock is currently priced at $5.05, with a 24-hour trading volume of 21,950. It has seen a -0.20% decreased in the last 24 hours and a -1.56% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $5.10 pivot point. If it approaches the $4.96 support level, significant changes may occur.

Previous Close:

$5.06

Open:

$5.15

24h Volume:

21,950

Market Cap:

$67.25M

Revenue:

Net Income/Loss:

$-24.05M

P/E Ratio:

-2.2545

EPS:

-2.24

Net Cash Flow:

$-17.78M

1W Performance:

-2.51%

1M Performance:

-1.56%

6M Performance:

+22.57%

1Y Performance:

+25.00%

1D Range:

$5.03

$5.1799

52W Range:

$2.51

$6.97

enVVeno Medical Corporation Stock (NVNO) Company Profile

Name

enVVeno Medical Corporation

Sector

Healthcare (1213)

Industry

Medical Devices (160)

Phone

949 261 2900

Address

70 Doppler, Irvine

Employee

Twitter

Next Earnings Date

2024-05-06

Latest SEC Filings

NVNO's Discussions on Twitter

enVVeno Medical Corporation Stock (NVNO) Financials Data

enVVeno Medical Corporation (NVNO) Net Income 2024

NVNO net income (TTM) was -$24.05 million for the quarter ending September 30, 2023, a +12.48% increase year-over-year.

enVVeno Medical Corporation (NVNO) Cash Flow 2024

NVNO recorded a free cash flow (TTM) of -$17.78 million for the quarter ending September 30, 2023, a -18.24% decrease year-over-year.

enVVeno Medical Corporation (NVNO) Earnings per Share 2024

NVNO earnings per share (TTM) was -$2.15 for the quarter ending September 30, 2023, a +16.67% growth year-over-year.

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.